Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Burtness

Showing results (81-90 of 184) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinomaEirini Pectasides, Theodore Rampias, Panteleimon Kountourakis, et al.
Plos One|April 12, 2014
Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC)Eirini Pectasides, Theodoros Rampias, Clarence Sasaki, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 20, 2020
Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and NeckDaniel Jacobs, Kelly Olino, Henry S Park, et al.
European Journal of Cancer (Oxford, England : 1990)|January 12, 2024
A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305Athanassios Argiris, Yael Flamand, Panayiotis Savvides, et al.
Head & Neck|September 20, 2011
Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experienceGenevieve Andrews, Miriam Lango, Roger Cohen, et al.
Cancer Biology & Therapy|March 19, 2003
Phase I dose escalation trial of weekly docetaxel plus irinotecan in patients with advanced cancerEric Bleickardt, Athanassios Argiris, Randy Rich, et al.
JAAD International|May 30, 2023
Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety, and tolerabilityAnnika Belzer, Jolanta Pach, Ryland D Mortlock, et al.
Thyroid : Official Journal of the American Thyroid Association|February 21, 2013
Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progressionMiriam Lango, Douglas Flieder, Rodrigo Arrangoiz, et al.
Oral Oncology|October 21, 2019
Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth editionJoseph A Miccio, Vivek Verma, Jacqueline Kelly, et al.
Oral Oncology|June 11, 2019
Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatmentLiliya Benchetrit, Sina J Torabi, Janet P Tate, et al.
Pageof 19

Showing results (81-90 of 184) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinomaEirini Pectasides, Theodore Rampias, Panteleimon Kountourakis, et al.
Plos One|April 12, 2014
Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC)Eirini Pectasides, Theodoros Rampias, Clarence Sasaki, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 20, 2020
Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and NeckDaniel Jacobs, Kelly Olino, Henry S Park, et al.
European Journal of Cancer (Oxford, England : 1990)|January 12, 2024
A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305Athanassios Argiris, Yael Flamand, Panayiotis Savvides, et al.
Head & Neck|September 20, 2011
Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experienceGenevieve Andrews, Miriam Lango, Roger Cohen, et al.
Cancer Biology & Therapy|March 19, 2003
Phase I dose escalation trial of weekly docetaxel plus irinotecan in patients with advanced cancerEric Bleickardt, Athanassios Argiris, Randy Rich, et al.
JAAD International|May 30, 2023
Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety, and tolerabilityAnnika Belzer, Jolanta Pach, Ryland D Mortlock, et al.
Thyroid : Official Journal of the American Thyroid Association|February 21, 2013
Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progressionMiriam Lango, Douglas Flieder, Rodrigo Arrangoiz, et al.
Oral Oncology|October 21, 2019
Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth editionJoseph A Miccio, Vivek Verma, Jacqueline Kelly, et al.
Oral Oncology|June 11, 2019
Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatmentLiliya Benchetrit, Sina J Torabi, Janet P Tate, et al.
Pageof 19